The autophagy activator rapamycin reversed the inhibitory effect of PEDF on the proliferative activity of NSCLC cells, whereas the autophagy inhibitor BAF1 had no effect (Fig. 3C). Here, SERPINF1 is linked to non-small cell lung carcinoma.